-
Mashup Score: 0The Future of AI in Cancer Care - The ASCO Post - 7 month(s) ago
New research has illustrated the strides being made to apply modern artificial intelligence (AI) computing methods to oncology, according to new findings to be presented at the European Society for Medical Oncology (ESMO) Congress 2023. Researchers have long investigated the potential of AI to transform cancer care and improve patient outcomes. According to Amara’s Law, individuals tend to overestimate the short-term impacts of technology but underestimate its long-term effects. However, caution may be
Source: ascopost.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Home Page: ESMO Real World Data and Digital Oncology - 7 month(s) ago
ESMO Real-World Data and Digital Oncology is the European Society for Medical Oncology’s latest peer-reviewed open access journal. It is dedicated to publishing high-quality data science and educational content on the transformation of oncology care with real-world evidence and digital technologies that physicians can trust and understand. The journal will publish innovative research that provides actionable insights from real-world data sources and digital devices, such as generalizable observational
Source: www.esmorwd.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
➡️Guidelines for RWD reporting ➡️ChatGPT in medical research ➡️ESMO RWD & Digital Oncology vision and mission https://t.co/o8SQzPwre7 DO NOT MISS THE FIRST ONLINE PAPERS❗️ https://t.co/oY3FevCg3e
-
-
Mashup Score: 1Home Page: ESMO Real World Data and Digital Oncology - 7 month(s) ago
ESMO Real-World Data and Digital Oncology is the European Society for Medical Oncology’s latest peer-reviewed open access journal. It is dedicated to publishing high-quality data science and educational content on the transformation of oncology care with real-world evidence and digital technologies that physicians can trust and understand. The journal will publish innovative research that provides actionable insights from real-world data sources and digital devices, such as generalizable observational
Source: www.esmorwd.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
This work represents a milestone for #RWD studies in #oncology ! ➡️ Access ESMO RWD and Digital Oncology content here: https://t.co/o8SQzPwre7 @OncologyAdvance @myESMO https://t.co/qqe8b2SKB0
-
-
Mashup Score: 1The future of real-world research is now - 7 month(s) ago
ESMO is at the forefront of digital oncology with initiatives to support oncologists navigate the emerging opportunities in the field of RWD reseaech
Source: dailyreporter.esmo.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
➡️The future of #RWD research is now! @myESMO daily reporter editorial presenting ESMO Real-World Data and Digital Oncology Journal. Proud to be part of this journey❗️ ➡️Go-to journal for health technology innovation in oncology care! https://t.co/wrCDMsnilZ https://t.co/YyygFpxkc2
-
-
Mashup Score: 1Home Page: ESMO Real World Data and Digital Oncology - 7 month(s) ago
ESMO Real-World Data and Digital Oncology is the European Society for Medical Oncology’s latest peer-reviewed open access journal. It is dedicated to publishing high-quality data science and educational content on the transformation of oncology care with real-world evidence and digital technologies that physicians can trust and understand. The journal will publish innovative research that provides actionable insights from real-world data sources and digital devices, such as generalizable observational
Source: www.esmorwd.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
▶️ Go-to journal for #RWD and #digitalhealth research in oncology! https://t.co/pSUvDOWART @flatironhealth @GroupeUnicancer @BCPlatforms @TriNetX @OwkinScience @PromptlyHealth @IQVIA_global @GetReal_Inst @aetioninc @ProstatePioneer @HarmonynetEU @BD4BO @RWE4Decisions @idea4rc https://t.co/3ISR8QFLpg
-
-
Mashup Score: 1
Welcome! You are invited to join a meeting: Quintas Moleculares 29/7. After registering, you will receive a confirmation email about joining the meeting.
Source: Zoom Video CommunicationsCategories: Hem/Oncs, Latest HeadlinesTweet-
*Quinta é dia de Quintas Moleculares* Implicações terapêuticas de painel hereditário em pacientes com câncer avançado. 19h Brasil *Link de acesso a reunião:* https://t.co/TxyJRf8LHa https://t.co/qyQDgtPBrX
-
-
Mashup Score: 0OncoTrialsTrack - 3 year(s) ago
Information displayed in OncoTrialsTrack is constantly updated but specific clinical trial recruitment plans may change on a daily basis. Therefore, clinical trial availability must be confirmed with principal investigators of the site. …
Source: oncotrialstrack.vhio.netCategories: Hem/Oncs, Latest HeadlinesTweet-
✅OncoTrialsTrack https://t.co/3gqyZxCdQp is a ❗️GREAT❗️ 🆒 tool to find biomarker-guided #clinicaltrial to cancer patients, supported by @EUCANCan_ @VHIO. @krys987 @aapedrol Check out this 🆒 article https://t.co/BPl0Qu0pXS
-
-
Mashup Score: 2
Tumour evolution is one of the primary reasons for resistance to treatment and researchers are now learning how to use it to lead tumours down a dead end
Source: perspectives.esmo.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
❗️TUMOR EVOLUTION ❗️is critical determinant of: 🔄 temporal and spatial heterogeneity; ↔️ cancer cell - microenvironment interaction; ⏭ resistance to therapies Check out this @myESMO #ESMOPerspectives paper by @NickyMcGranahan https://t.co/baZFsry1jH
-
-
Mashup Score: 0
Welcome! You are invited to join a meeting: SEMINÁRIO DE ONCOLOGIA TRANSLACIONAL . After registering, you will receive a confirmation email about joining the meeting.
Source: Zoom VideoCategories: Hem/Oncs, Latest HeadlinesTweet-
Happy to moderate session with Prof Yousef Yarden from @WeizmannScience REGISTRATION ➡️ https://t.co/9sUmNqor09 https://t.co/E8WJoUvtWo
-
-
Mashup Score: 2Genomic testing for targeted oncology drugs: hopes against hype. - 3 year(s) ago
Precision medicine entails access to genomic testing, including single gene assays and/or large next-generation sequencing (NGS) panels, in a given time point of the patient’s disease trajectory; data interpretation and reporting to physicians with acceptable turn-around times for straightforward decision making or case discussion; and access to drugs (preferably at the point-of-care) with…
Source: Annals of OncologyCategories: Hem/Oncs, Latest HeadlinesTweet-
✅Genomic-cancer associations to targeted oncology drugs have increased from 6 to over 60 in the last decade❗️ ✅Check the shape of the curve in the last 2 years⬇️and read our @Annals_Oncology editorial for prospects and challenges ahead https://t.co/WvqEhd2Fsa (1/2) https://t.co/f39k0cEcfz
-
➡️Future of AI in cancer care @ASCOPost article linking ESMO GROW (#RWD reporting standards) with #AI applied to #oncology and the new @myESMO RWD and Digital Oncology Journal @OncologyAdvance https://t.co/3b1VrgQxVb https://t.co/oKksEd8wyR